AUTOLUS THERAPEUTICS PLC

AUTL NASDAQ
9.91
-0.11
-1.10%
盘后: 9.91 0 0.00% 16:32 08/16 EDT
开盘
9.97
昨收
10.02
最高
10.20
最低
9.61
成交量
14.40万
成交均量(3M)
12.75万
52周最高
53.24
52周最低
9.53
换手率
0.38%
市值
3.74亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供AUTOLUS THERAPEUTICS PLC AUTL股票价格,AUTOLUS THERAPEUTICS PLC股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Autolus Therapeutics plc, formerly Autolus Therapeutics Limited, is a development-stage biopharmaceutical company. The company is engaged in developing programmed T-cell therapies for the treatment of cancer. The Company's clinical-stage product candidates target hematological cancers. Its products candidates include AUTO2, AUTO3, AUTO4, and AUTO6. AUTO2 is a dual-targeting programmed T-cell therapy for the treatment of relapsed or refractory multiple myeloma targeting B-cell Maturation Antigen and the transmembrane activator. AUTO3 is a T-cell therapy for the treatment of relapsed or refractory diffuse large B-cell lymphoma and pediatric relapsed acute B lymphocytic leukemia. Its AUTO4 is a T-cell therapy for the treatment of peripheral T-cell lymphoma.
展开 >

最近浏览

名称
价格
涨跌幅